Table 2.
#a | Haplotypeb | Frequency (cases) |
Frequency (controls) |
OR (95% CI) | p-value | ||||
---|---|---|---|---|---|---|---|---|---|
1 | 259 or 261 | T | A | T | T | 0.483 | 0.554 | Reference | |
2 | 259 or 261 | C | G | C | C | 0.273 | 0.223 | 1.43 (1.29–1.59) | 4.1 × 10−11 |
3 | 263 | T | G | T | C | 0.070 | 0.053 | 1.49 (1.20–1.86) | 3.7 × 10−4 |
4 | 259 or 261 | T | G | T | T | 0.042 | 0.050 | 0.93 (0.73–1.20) | 0.600 |
5 | 259 or 261 | T | A | C | C | 0.048 | 0.046 | 1.24 (0.99–1.55) | 0.055 |
6 | 259 or 261 | C | G | T | T | 0.028 | 0.029 | 1.16 (0.88–1.53) | 0.292 |
7 | 259 or 261 | T | G | T | C | 0.023 | 0.020 | 1.30 (0.96–1.76) | 0.094 |
Data presented are for the combined sample in an additive model adjusted for age and sex
Haplotypes are numbered in order of descending frequency in controls
Haplotypes comprised of REP1, rs2619364, rs2737029, rs2572324, and rs356219 (in that order). REP1 alleles 259 and 261 were grouped together. Haplotypes with an estimated frequency < 0.01 in cases and controls were excluded.
OR = odds ratio; CI = confidence interval